China healthcare investment booms on virus-related spending bets

China healthcare investment booms on virus-related spending bets

Photo: Pixabay

China’s healthcare and biotech firms are capitalising on a surge of interest in the sector due to the coronavirus pandemic by raising a record $6.8 billion in fresh equity-linked transactions this year.

While healthcare and related sectors have long been popular, with investors betting that China’s ageing population and growing middle class would boost spending, the virus has raised expectations that Beijing will funnel even more funds into them.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter